Science

Antibacterial compounds are no longer in your hand soap, but they’re in your floors, your walls, and in your body. by Maryn McKenna

This tech could boost fertility and fine-tune hormone levels.

He built a powerful system for launching scientific ideas into startups. Can he do it again? by Po Bronson

Researching orgasms gives this reviewer some perspective on the new comedy by Whitney Cummings.

We’re only talking legal sales here.

Can we create people who are optimized for ultra-long space travel?

Scientists and entrepreneurs tell us what they’re looking for.

Maverick scientists, a blissful free diver, and (of course) sex and drugs lit up our top articles of the year.

Gregory Stock is ready for cloning, gene editing, and conscious AI. But first he’s trying to get you better health care.

In “The Runaway Species,” Anthony Brandt and David Eagleman try to unlock the secrets of creativity. by Michael Hawley

A thriller about cloning, gene editing, and bioengineering is the perfect show for our times.

MIT dropout Laura Deming is on the hunt for causes of disease and mechanisms for quashing it.

The strange saga of a dying researcher desperate to cure herpes.

Dogfish sharks produce a remarkable antibacterial compound that might halt symptoms of Parkinson’s disease.

Elite athletes have a greater variety of bacteria in their guts than couch potatoes do, raising the prospect of “poop doping.”